Trials / Completed
CompletedNCT03002545
Magnesium Supplementation in Type II Diabetes
Effects of a 12-week Supplementation With 400 mg Magnesium From Magnesium Citrate on Blood Sugar, Blood Pressure and Expression of Magnesium-sensitive Genes in Patients With Type II Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Protina Pharmazeutische GmbH · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine how a 12-week magnesium supplementation with 400 mg magnesium from organic magnesium citrate affects blood glucose control and insulin resistance within patients with type 2 diabetes (HbA1c\> 6%) and how the expression of certain Mg-sensitive transporting genes is affected .
Detailed description
The examinations are carried out in 50 subjects aged 20-80 years with existing type 2 diabetes (HbA1c\> 6%). The target parameters are determined in the blood. Blood sampling takes place at confinement, after 6 weeks and at the end of the study (week 12). In addition, blood pressure is determined and general health condition of each subject is recorded by a standardized questionnaire (SF-36).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Magnesium citrate | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-03-01
- Completion
- 2019-07-01
- First posted
- 2016-12-23
- Last updated
- 2019-08-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03002545. Inclusion in this directory is not an endorsement.